Quarter-over-quarter and year-over-year time series from SEC company facts — every whitelisted metric with deltas, ratios, and anomaly flags.
Coverage
21 of 25 metrics reported
4 not in filing history
Selected
$1.63B
2026-03-31 · quarterly · YoY 157.4%
| Period end | Frequency | Value | QoQ | YoY | Flag |
|---|---|---|---|---|---|
| 2026-03-31 | quarterly | $1.63B | -46.8% | +157.4% | |
| 2025-09-30 | quarterly | $3.07B | +62.6% | +89.8% | |
| 2025-06-30 | quarterly | $1.89B | +113.6% | +78.3% | Anomaly |
| 2025-03-31 | quarterly | $884M | -56.6% | +39.3% | |
| 2024-09-30 | quarterly | $2.04B | +55.3% | +26.1% | |
| 2024-06-30 | quarterly | $1.31B | +106.9% | +24.0% | Anomaly |
| 2024-03-31 | quarterly | $634M | -60.8% | +20.8% | |
| 2023-09-30 | quarterly | $1.62B | +52.7% | +15.7% | |
| 2023-06-30 | quarterly | $1.06B | +101.5% | +15.1% | Anomaly |
| 2023-03-31 | quarterly | $525M | -62.4% | +17.7% | |
| 2022-09-30 | quarterly | $1.40B | +52.0% | +26.0% | |
| 2022-06-30 | quarterly | $919M | +106.0% | +28.2% | Anomaly |
| 2022-03-31 | quarterly | $446M | -59.8% | +30.8% | |
| 2021-09-30 | quarterly | $1.11B | +54.7% | +43.9% | |
| 2021-06-30 | quarterly | $717M | +110.1% | +49.0% | Anomaly |
| 2021-03-31 | quarterly | $341M | -55.7% | +48.8% | |
| 2020-09-30 | quarterly | $771M | +60.1% | — | |
| 2020-06-30 | quarterly | $481M | +109.8% | — | Anomaly |
| 2020-03-31 | quarterly | $229M | — | — |
revenue · magnitude 109.8%
revenue · magnitude 110.1%
revenue · magnitude 106.0%
revenue · magnitude 101.5%
revenue · magnitude 106.9%
revenue · magnitude 113.6%
| Metric | Status | Annual | Quarterly | Gaps |
|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | reported | 8 | 19 | 6 |
| Cost Of Goods And Services Sold | not reported | 0 | 0 | 0 |
| Gross Profit | reported | 8 | 20 | 7 |
| Research And Development Expense | reported | 8 | 20 | 7 |
| Selling General And Administrative Expense | not reported | 0 | 0 | 0 |
| Operating Income Loss | reported | 8 | 20 | 7 |
| Net Income Loss | reported | 8 | 20 | 7 |
| EPS Basic | reported | 8 | 20 | 7 |
| EPS Diluted | reported | 8 | 20 | 7 |
| Cash And Cash Equivalents At Carrying Value | reported | 8 | 27 | 7 |
| Accounts Receivable Net Current | reported | 7 | 24 | 16 |
| Inventory Net | not reported | 0 | 0 | 0 |
| Assets Current | reported | 7 | 24 | 16 |
| Assets | reported | 7 | 24 | 16 |
| Liabilities Current | reported | 7 | 24 | 16 |
| Long Term Debt Non-current | reported | 3 | 4 | 3 |
| Liabilities | reported | 7 | 24 | 16 |
| Stockholders Equity | reported | 9 | 29 | 17 |
| Net Cash Provided By Used In Operating Activities | reported | 8 | 20 | 7 |
| Net Cash Provided By Used In Investing Activities | reported | 8 | 20 | 7 |
| Net Cash Provided By Used In Financing Activities | reported | 8 | 20 | 7 |
| Entity Common Stock Shares Outstanding | not reported | 0 | 0 | 0 |
| Weighted Average Number Of Shares Outstanding Basic | reported | 8 | 20 | 7 |
| Weighted Average Number Of Diluted Shares Outstanding | reported | 8 | 20 | 7 |
| Common Stock Shares Authorized | reported | 7 | 24 | 16 |